DUBLIN–(BUSINESS WIRE)–The “Molecular Diagnostics for Infectious Disease By Syndrome, Plex, Place and by Country. With COVID-19 Impact & Forecasting/Analysis, and Executive Guides and Customization 2022-2026” report has been added to ResearchAndMarkets.com’s offering.
COVID-19 Drives a surge in demand but what is the long term impact? The microbiology lab may disappear while multiplex takes center stage.
The Molecular Diagnostics – Infectious Disease sector of the clinical diagnostics industry is poised for record growth. A market that just keeps on growing but is spiking as an enormous C19Dx demand sweeps over the globe. Find out what the numbers are in this informative report. And find out about the exciting developments in multiplex assays which threaten to change diagnosis and treatment while limiting the threat of anti microbial drug resistance.
Infectious disease testing directly benefits from the explosion in biotechnology, especially genomics. Learn all about it in this report. A range of dynamic trends are pushing market growth and company valuations.
Trends like:
- Multiplex testing
- pathogen evolution and pandemics
- biotechnology advances in genetics
- climate change
- globalization
- the rise of rapid testing
Exciting technical developments especially in the seesaw between nucleic acid testing and immunoassay, hold the promise of a dynamic, growing and evolving world market that holds the promise of diagnostics taking the lead in infectious disease eradication.
The report has hundreds of pages of information including a complete list of Current United States Medicare Fee Payment Schedules to help sharpen your pricing. Again, assistance in using the information is normally provided without additional charges. The report includes detailed breakouts for 15 Countries and 4 Regions. A detailed breakout for any country in the world is available to purchasers of the report.
Market Dynamics
Drivers
- New Genotypes Creating New Markets
- Aging Population a Boon for All Diagnostics
- Developing World Driving ID Dx Growth
- Point of Care – Why Centralization is Losing Steam
- Self Testing
- The Need for Speed
- The COVID Pandemic
Restraints
- Lower Costs
- Infectious Disease is Declining
- Wellness Hurts
- Economic Growth improves Living Standards
Companies Mentioned
- 1928 Diagnostics
- Abacus Diagnostica
- Abbott Laboratories
- Accelerate Diagnostics
- Access Bio
- Ador Diagnostics
- ADT Biotech
- Akonni Biosystems
- Altona Diagnostics
- Alveo Technologies
- Anatolia Geneworks
- Antelope Dx
- Applied BioCode
- Assurance Scientific Laboratories
- Aureum Diagnostics
- Aus Diagnostics
- Beckman Coulter Diagnostics
- Becton, Dickinson and Company
- Binx Health
- Biocartis
- BioFire Diagnostics (bioMerieux)
- bioMerieux Diagnostics
- Bio-Rad Laboratories, Inc
- Bosch Healthcare Solutions GmbH
- Celemics
- Cepheid (Danaher)
- Chembio
- Co Diagnostics
- Credo Diagnostics Biomedical
- Cue Health
- Curetis N.V./Curetis GmbH
- Detect
- Diagenode Diagnostics
- Diascopic
- Diasorin S.p.A.
- Eiken Chemical
- Enzo Biochem
- Eurofins Scientific
- Fluxergy
- Fulgent Genetics
- Fusion Genomics.
- Genedrive
- Genetic Signatures
- GenMark Dx (Roche)
- Grifols
- Grip Molecular Technologies
- Hibergene Diagnostics
- Hologic
- Illumina
- Immunexpress
- Inflammatix
- Invetech
- Janssen Diagnostics
- Karius
- Lexagene
- LightDeck Diagnostics
- Lucira Health
- Luminex Corp
- LumiraDx
- Lumos Diagnostics
- Mammoth Biosciences
- Maxim Biomedical
- Meridian Bioscience
- Mesa Biotech (Thermo Fisher)
- Millipore Sigma
- Mindray
- Mobidiag (Hologic)
- Molbio Diagnostics
- Nanomix
- Novacyt
- Novel Microdevices
- Operon
- Oxford Nanopore Technologies
- Panagene
- Pathogenomix
- Perkin Elmer
- Prenetics
- Primerdesign (Novacyt)
- Prominex
- Qiagen
- QuantuMDx
- Quest Diagnostics
- Quidel
- Randox Toxicology
- Roche Molecular Diagnostics
- Saw Diagnostics
- SD Biosensor
- Seegene
- Siemens Healthineers
- SomaLogic
- Sona Nanotech
- SpeeDx
- T2 Biosystems
- Talis Biomedical
- Thermo Fisher Scientific Inc.
- Veramarx
- Veredus Laboratories
- Vir
- Vircell
- Visby Medical
- XCR Diagnostics
- YD Diagnostics
- Zhejiang Orient Gene Biotech
For more information about this report visit https://www.researchandmarkets.com/r/pptbxv
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900